[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:testicular-germ-cell-tumor":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":35,"states":36},"Testicular Germ Cell Tumor",4,[7,15,22,29],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07218913","Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors",[11],"Phase 1","RECRUITING","2026-08-26T02:17:18.747857Z","2026-05-05T02:35:31.932548Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT06041503","Enfortumab Vedotin With or Without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE)",[19],"Phase 2","2026-08-26T02:15:30.699880Z","2026-05-05T02:43:28.518599Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":27,"content_modified":28},"NCT03067181","Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors",[26],"Phase 3","2026-08-26T02:15:52.238965Z","2026-05-05T02:43:28.483905Z",{"nct_id":30,"title":31,"phases":32,"status":12,"updated_at":33,"content_modified":34},"NCT06060873","MAGESTIC Trial: MiRNA in Detecting Active Germ Cell Tumors in Early Suspected and MetastaTIC Disease Trial",[],"2026-08-26T02:18:26.129155Z","2026-05-13T02:55:06.406172Z",[],[37],{"state":38,"count":39,"slug":40},"California",3,"california"]